25 XP   0   0   10

HLB Life Science Co.Ltd
Buy, Hold or Sell?

Let's analyse HLB Life Science Co.Ltd together

PenkeI guess you are interested in HLB Life Science Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of HLB Life Science Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about HLB Life Science Co.Ltd

I send you an email if I find something interesting about HLB Life Science Co.Ltd.

Quick analysis of HLB Life Science Co.Ltd (30 sec.)










What can you expect buying and holding a share of HLB Life Science Co.Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩2,163.19
Expected worth in 1 year
₩1,885.52
How sure are you?
41.2%

+ What do you gain per year?

Total Gains per Share
₩-277.66
Return On Investment
-1.7%

For what price can you sell your share?

Current Price per Share
₩16,700.00
Expected price per share
₩14,010 - ₩25,000
How sure are you?
50%

1. Valuation of HLB Life Science Co.Ltd (5 min.)




Live pricePrice per Share (EOD)

₩16,700.00

Intrinsic Value Per Share

₩-8,146.86 - ₩-9,685.27

Total Value Per Share

₩-5,983.67 - ₩-7,522.08

2. Growth of HLB Life Science Co.Ltd (5 min.)




Is HLB Life Science Co.Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$161.8m$180.2m-$15.1m-9.2%

How much money is HLB Life Science Co.Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1m-$9.4m$8.4m807.1%
Net Profit Margin-12.3%-55.1%--

How much money comes from the company's main activities?

3. Financial Health of HLB Life Science Co.Ltd (5 min.)




4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#177 / 393

Most Revenue
#295 / 393

Most Profit
#322 / 393

Most Efficient
#337 / 393

What can you expect buying and holding a share of HLB Life Science Co.Ltd? (5 min.)

Welcome investor! HLB Life Science Co.Ltd's management wants to use your money to grow the business. In return you get a share of HLB Life Science Co.Ltd.

What can you expect buying and holding a share of HLB Life Science Co.Ltd?

First you should know what it really means to hold a share of HLB Life Science Co.Ltd. And how you can make/lose money.

Speculation

The Price per Share of HLB Life Science Co.Ltd is ₩16,700. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of HLB Life Science Co.Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in HLB Life Science Co.Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,163.19. Based on the TTM, the Book Value Change Per Share is ₩-69.42 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-3.65 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of HLB Life Science Co.Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.040.0%-0.010.0%-0.100.0%-0.050.0%-0.050.0%
Usd Book Value Change Per Share-0.030.0%-0.050.0%0.000.0%0.090.0%0.090.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.030.0%-0.050.0%0.000.0%0.090.0%0.090.0%
Usd Price Per Share8.02-7.30-8.02-11.59-11.59-
Price to Earnings Ratio47.42-6.77-11.42-22.76-22.76-
Price-to-Total Gains Ratio-245.64-81.17--7.64-58.12-58.12-
Price to Book Ratio5.29-4.56-4.44-5.10-5.10-
Price-to-Total Gains Ratio-245.64-81.17--7.64-58.12-58.12-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.69
Number of shares85
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.09
Usd Total Gains Per Share-0.050.09
Gains per Quarter (85 shares)-4.137.57
Gains per Year (85 shares)-16.5230.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-17-2703020
20-33-4406150
30-50-6109180
40-66-780121110
50-83-950151140
60-99-1120182170
70-116-1290212200
80-132-1460242230
90-149-1630273260
100-165-1800303290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%5.07.00.041.7%8.09.00.047.1%8.09.00.047.1%8.09.00.047.1%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%7.010.00.041.2%7.010.00.041.2%7.010.00.041.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%7.010.00.041.2%7.010.00.041.2%7.010.00.041.2%

Fundamentals of HLB Life Science Co.Ltd

About HLB Life Science Co.Ltd

  • Other

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of HLB Life Science Co.Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit HLB Life Science Co.Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare HLB Life Science Co.Ltd to the Other industry mean.
  • A Net Profit Margin of 27.4% means that ₩0.27 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of HLB Life Science Co.Ltd:

  • The MRQ is 27.4%. The company is making a huge profit. +2
  • The TTM is -12.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ27.4%TTM-12.3%+39.7%
TTM-12.3%YOY-55.1%+42.8%
TTM-12.3%5Y-43.6%+31.3%
5Y-43.6%10Y-43.6%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ27.4%5.2%+22.2%
TTM-12.3%5.6%-17.9%
YOY-55.1%7.0%-62.1%
5Y-43.6%5.9%-49.5%
10Y-43.6%5.6%-49.2%
1.1.2. Return on Assets

Shows how efficient HLB Life Science Co.Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare HLB Life Science Co.Ltd to the Other industry mean.
  • 1.5% Return on Assets means that HLB Life Science Co.Ltd generated ₩0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of HLB Life Science Co.Ltd:

  • The MRQ is 1.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is -0.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.5%TTM-0.4%+1.9%
TTM-0.4%YOY-3.7%+3.3%
TTM-0.4%5Y-2.8%+2.4%
5Y-2.8%10Y-2.8%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%1.2%+0.3%
TTM-0.4%1.4%-1.8%
YOY-3.7%1.7%-5.4%
5Y-2.8%1.4%-4.2%
10Y-2.8%1.4%-4.2%
1.1.3. Return on Equity

Shows how efficient HLB Life Science Co.Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare HLB Life Science Co.Ltd to the Other industry mean.
  • 2.8% Return on Equity means HLB Life Science Co.Ltd generated ₩0.03 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of HLB Life Science Co.Ltd:

  • The MRQ is 2.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -0.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.8%TTM-0.8%+3.6%
TTM-0.8%YOY-6.1%+5.3%
TTM-0.8%5Y-3.6%+2.9%
5Y-3.6%10Y-3.6%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8%3.6%-0.8%
TTM-0.8%3.9%-4.7%
YOY-6.1%5.3%-11.4%
5Y-3.6%4.1%-7.7%
10Y-3.6%4.3%-7.9%

1.2. Operating Efficiency of HLB Life Science Co.Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient HLB Life Science Co.Ltd is operating .

  • Measures how much profit HLB Life Science Co.Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare HLB Life Science Co.Ltd to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of HLB Life Science Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-13.1%+13.1%
5Y-13.1%10Y-13.1%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.9%-10.9%
TTM-9.5%-9.5%
YOY-8.9%-8.9%
5Y-13.1%6.1%-19.2%
10Y-13.1%7.5%-20.6%
1.2.2. Operating Ratio

Measures how efficient HLB Life Science Co.Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 2.43 means that the operating costs are ₩2.43 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of HLB Life Science Co.Ltd:

  • The MRQ is 2.428. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.280. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.428TTM2.280+0.147
TTM2.280YOY2.223+0.057
TTM2.2805Y2.195+0.085
5Y2.19510Y2.1950.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4281.258+1.170
TTM2.2801.258+1.022
YOY2.2231.214+1.009
5Y2.1951.257+0.938
10Y2.1951.359+0.836

1.3. Liquidity of HLB Life Science Co.Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if HLB Life Science Co.Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 1.09 means the company has ₩1.09 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of HLB Life Science Co.Ltd:

  • The MRQ is 1.086. The company is just able to pay all its short-term debts.
  • The TTM is 3.328. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.086TTM3.328-2.243
TTM3.328YOY10.665-7.337
TTM3.3285Y8.168-4.840
5Y8.16810Y8.1680.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0861.437-0.351
TTM3.3281.504+1.824
YOY10.6651.536+9.129
5Y8.1681.478+6.690
10Y8.1681.478+6.690
1.3.2. Quick Ratio

Measures if HLB Life Science Co.Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare HLB Life Science Co.Ltd to the Other industry mean.
  • A Quick Ratio of 0.54 means the company can pay off ₩0.54 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of HLB Life Science Co.Ltd:

  • The MRQ is 0.543. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 2.034. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.543TTM2.034-1.491
TTM2.034YOY6.356-4.322
TTM2.0345Y5.535-3.502
5Y5.53510Y5.5350.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5430.552-0.009
TTM2.0340.604+1.430
YOY6.3560.591+5.765
5Y5.5350.608+4.927
10Y5.5350.603+4.932

1.4. Solvency of HLB Life Science Co.Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of HLB Life Science Co.Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare HLB Life Science Co.Ltd to Other industry mean.
  • A Debt to Asset Ratio of 0.45 means that HLB Life Science Co.Ltd assets are financed with 45.4% credit (debt) and the remaining percentage (100% - 45.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of HLB Life Science Co.Ltd:

  • The MRQ is 0.454. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.438. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.454TTM0.438+0.016
TTM0.438YOY0.295+0.143
TTM0.4385Y0.243+0.195
5Y0.24310Y0.2430.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4540.529-0.075
TTM0.4380.529-0.091
YOY0.2950.551-0.256
5Y0.2430.558-0.315
10Y0.2430.570-0.327
1.4.2. Debt to Equity Ratio

Measures if HLB Life Science Co.Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare HLB Life Science Co.Ltd to the Other industry mean.
  • A Debt to Equity ratio of 83.3% means that company has ₩0.83 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of HLB Life Science Co.Ltd:

  • The MRQ is 0.833. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.784. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.833TTM0.784+0.050
TTM0.784YOY0.469+0.315
TTM0.7845Y0.370+0.413
5Y0.37010Y0.3700.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8331.100-0.267
TTM0.7841.105-0.321
YOY0.4691.180-0.711
5Y0.3701.294-0.924
10Y0.3701.447-1.077

2. Market Valuation of HLB Life Science Co.Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings HLB Life Science Co.Ltd generates.

  • Above 15 is considered overpriced but always compare HLB Life Science Co.Ltd to the Other industry mean.
  • A PE ratio of 47.42 means the investor is paying ₩47.42 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of HLB Life Science Co.Ltd:

  • The EOD is 69.159. Based on the earnings, the company is expensive. -2
  • The MRQ is 47.418. Based on the earnings, the company is overpriced. -1
  • The TTM is 6.771. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD69.159MRQ47.418+21.742
MRQ47.418TTM6.771+40.647
TTM6.771YOY11.416-4.645
TTM6.7715Y22.756-15.986
5Y22.75610Y22.7560.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD69.15913.154+56.005
MRQ47.41810.391+37.027
TTM6.77110.456-3.685
YOY11.41611.890-0.474
5Y22.75612.374+10.382
10Y22.75612.368+10.388
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of HLB Life Science Co.Ltd:

  • The EOD is -33.236. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -22.787. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 2,600.417. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-33.236MRQ-22.787-10.448
MRQ-22.787TTM2,600.417-2,623.204
TTM2,600.417YOY-75.226+2,675.643
TTM2,600.4175Y780.049+1,820.368
5Y780.04910Y780.0490.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-33.2365.099-38.335
MRQ-22.7874.250-27.037
TTM2,600.4175.552+2,594.865
YOY-75.2262.561-77.787
5Y780.0491.673+778.376
10Y780.0493.589+776.460
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of HLB Life Science Co.Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 5.29 means the investor is paying ₩5.29 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of HLB Life Science Co.Ltd:

  • The EOD is 7.720. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.293. Based on the equity, the company is overpriced. -1
  • The TTM is 4.562. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD7.720MRQ5.293+2.427
MRQ5.293TTM4.562+0.732
TTM4.562YOY4.440+0.122
TTM4.5625Y5.103-0.541
5Y5.10310Y5.1030.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD7.7201.753+5.967
MRQ5.2931.361+3.932
TTM4.5621.359+3.203
YOY4.4401.575+2.865
5Y5.1031.489+3.614
10Y5.1031.619+3.484
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of HLB Life Science Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---46.614-69.416+49%-3.646-92%127.246-137%127.246-137%
Book Value Per Share--2163.1862290.688-6%2577.604-16%2369.187-9%2369.187-9%
Current Ratio--1.0863.328-67%10.665-90%8.168-87%8.168-87%
Debt To Asset Ratio--0.4540.438+4%0.295+54%0.243+87%0.243+87%
Debt To Equity Ratio--0.8330.784+6%0.469+78%0.370+125%0.370+125%
Dividend Per Share----0%-0%-0%-0%
Eps--60.368-15.442+126%-141.383+334%-76.484+227%-76.484+227%
Free Cash Flow Per Share---125.617-75.894-40%-104.047-17%-66.655-47%-66.655-47%
Free Cash Flow To Equity Per Share---125.617-75.894-40%-104.047-17%-66.655-47%-66.655-47%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---9685.268--------
Intrinsic Value_10Y_min---8146.857--------
Intrinsic Value_1Y_max---395.822--------
Intrinsic Value_1Y_min---388.455--------
Intrinsic Value_3Y_max---1627.280--------
Intrinsic Value_3Y_min---1544.694--------
Intrinsic Value_5Y_max---3386.801--------
Intrinsic Value_5Y_min---3105.843--------
Market Cap--1223837726950.0001075779135322.500+14%1144039090177.614+7%1447051442562.958-15%1447051442562.958-15%
Net Profit Margin--0.274-0.123+145%-0.551+301%-0.436+259%-0.436+259%
Operating Margin----0%-0%-0.1310%-0.1310%
Operating Ratio--2.4282.280+6%2.223+9%2.195+11%2.195+11%
Pb Ratio7.720+31%5.2934.562+16%4.440+19%5.103+4%5.103+4%
Pe Ratio69.159+31%47.4186.771+600%11.416+315%22.756+108%22.756+108%
Price Per Share16700.000+31%11450.00010427.500+10%11450.0030%16551.850-31%16551.850-31%
Price To Free Cash Flow Ratio-33.236-46%-22.7872600.417-101%-75.226+230%780.049-103%780.049-103%
Price To Total Gains Ratio-358.265-46%-245.63781.171-403%-7.641-97%58.123-523%58.123-523%
Quick Ratio--0.5432.034-73%6.356-91%5.535-90%5.535-90%
Return On Assets--0.015-0.004+126%-0.037+345%-0.028+282%-0.028+282%
Return On Equity--0.028-0.008+128%-0.061+318%-0.036+230%-0.036+230%
Total Gains Per Share---46.614-69.416+49%-3.646-92%127.246-137%127.246-137%
Usd Book Value--161849054.003165112027.526-2%180251940.888-10%192479702.492-16%192479702.492-16%
Usd Book Value Change Per Share---0.033-0.049+49%-0.003-92%0.089-137%0.089-137%
Usd Book Value Per Share--1.5141.603-6%1.804-16%1.658-9%1.658-9%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.042-0.011+126%-0.099+334%-0.054+227%-0.054+227%
Usd Free Cash Flow---9398671.296-5519177.706-41%-7244556.471-23%-4770557.340-49%-4770557.340-49%
Usd Free Cash Flow Per Share---0.088-0.053-40%-0.073-17%-0.047-47%-0.047-47%
Usd Free Cash Flow To Equity Per Share---0.088-0.053-40%-0.073-17%-0.047-47%-0.047-47%
Usd Market Cap--856686408.865753045394.726+14%800827363.124+7%1012936009.794-15%1012936009.794-15%
Usd Price Per Share11.690+31%8.0157.299+10%8.0150%11.586-31%11.586-31%
Usd Profit--4516718.311-1047095.019+123%-9498551.125+310%-6048490.457+234%-6048490.457+234%
Usd Revenue--16485544.52317148327.119-4%17428490.714-5%15935767.065+3%15935767.065+3%
Usd Total Gains Per Share---0.033-0.049+49%-0.003-92%0.089-137%0.089-137%
 EOD+2 -4MRQTTM+14 -18YOY+9 -235Y+9 -2310Y+9 -23

3.2. Fundamental Score

Let's check the fundamental score of HLB Life Science Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1569.159
Price to Book Ratio (EOD)Between0-17.720
Net Profit Margin (MRQ)Greater than00.274
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.543
Current Ratio (MRQ)Greater than11.086
Debt to Asset Ratio (MRQ)Less than10.454
Debt to Equity Ratio (MRQ)Less than10.833
Return on Equity (MRQ)Greater than0.150.028
Return on Assets (MRQ)Greater than0.050.015
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of HLB Life Science Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.331
Ma 20Greater thanMa 5018,820.000
Ma 50Greater thanMa 10017,015.800
Ma 100Greater thanMa 20014,140.600
OpenGreater thanClose16,640.000
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Tax Provision  -3,422,8312,411,638-1,011,193-51,101-1,062,293-87,068-1,149,3613,782,1452,632,784



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets423,500,448
Total Liabilities192,287,513
Total Stockholder Equity230,796,723
 As reported
Total Liabilities 192,287,513
Total Stockholder Equity+ 230,796,723
Total Assets = 423,500,448

Assets

Total Assets423,500,448
Total Current Assets147,043,191
Long-term Assets276,457,256
Total Current Assets
Cash And Cash Equivalents 16,768,575
Short-term Investments 62,091,109
Net Receivables 11,464,334
Inventory 5,266,832
Other Current Assets 1
Total Current Assets  (as reported)147,043,191
Total Current Assets  (calculated)95,590,850
+/- 51,452,341
Long-term Assets
Property Plant Equipment 72,918,303
Goodwill 1,772,113
Intangible Assets 54,028,698
Long-term Assets Other 0
Long-term Assets  (as reported)276,457,256
Long-term Assets  (calculated)128,719,114
+/- 147,738,142

Liabilities & Shareholders' Equity

Total Current Liabilities135,456,990
Long-term Liabilities56,830,524
Total Stockholder Equity230,796,723
Total Current Liabilities
Short Long Term Debt 113,821,148
Accounts payable 5,160,179
Other Current Liabilities 1,471
Total Current Liabilities  (as reported)135,456,990
Total Current Liabilities  (calculated)118,982,798
+/- 16,474,191
Long-term Liabilities
Long term Debt 51,410,004
Capital Lease Obligations Min Short Term Debt1,346,348
Long-term Liabilities Other -1
Long-term Liabilities  (as reported)56,830,524
Long-term Liabilities  (calculated)52,756,351
+/- 4,074,172
Total Stockholder Equity
Retained Earnings 10,430,563
Total Stockholder Equity (as reported)230,796,723
Total Stockholder Equity (calculated)10,430,563
+/- 220,366,160
Other
Capital Stock51,406,913
Common Stock Shares Outstanding 106,885
Net Debt 148,462,578
Net Invested Capital 396,027,876
Net Working Capital 11,586,202
Property Plant and Equipment Gross 99,222,656



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
387,260,388
433,128,162
354,609,771
404,935,130
379,528,734
375,108,333
364,979,127
327,196,942
308,184,050
295,947,670
333,100,695
270,799,569
255,576,197
367,434,498
484,721,182
411,790,371
426,713,922
414,268,092
414,435,179
423,500,448
423,500,448414,435,179414,268,092426,713,922411,790,371484,721,182367,434,498255,576,197270,799,569333,100,695295,947,670308,184,050327,196,942364,979,127375,108,333379,528,734404,935,130354,609,771433,128,162387,260,388
   > Total Current Assets 
199,826,267
189,228,774
111,958,074
223,667,024
189,346,911
188,742,227
167,480,133
181,328,966
165,653,215
153,088,959
207,300,847
156,822,300
131,614,062
245,792,974
230,009,089
160,775,696
173,459,361
64,452,111
96,646,547
147,043,191
147,043,19196,646,54764,452,111173,459,361160,775,696230,009,089245,792,974131,614,062156,822,300207,300,847153,088,959165,653,215181,328,966167,480,133188,742,227189,346,911223,667,024111,958,074189,228,774199,826,267
       Cash And Cash Equivalents 
16,135,043
71,008,892
13,771,668
36,768,747
23,789,637
24,210,341
8,966,207
37,156,998
46,006,703
55,656,932
36,429,117
31,253,621
31,299,748
127,091,363
52,938,272
30,978,386
30,373,522
32,033,333
23,582,400
16,768,575
16,768,57523,582,40032,033,33330,373,52230,978,38652,938,272127,091,36331,299,74831,253,62136,429,11755,656,93246,006,70337,156,9988,966,20724,210,34123,789,63736,768,74713,771,66871,008,89216,135,043
       Short-term Investments 
141,070,930
76,005,999
47,109,815
139,087,215
118,563,511
120,883,409
129,857,755
120,876,957
106,250,457
85,892,630
145,553,256
108,706,933
87,074,630
90,767,712
138,996,040
101,010,546
122,962,372
11,383,974
49,861,556
62,091,109
62,091,10949,861,55611,383,974122,962,372101,010,546138,996,04090,767,71287,074,630108,706,933145,553,25685,892,630106,250,457120,876,957129,857,755120,883,409118,563,511139,087,21547,109,81576,005,999141,070,930
       Net Receivables 
33,064,260
32,791,095
0
38,139,032
41,169,028
33,074,141
0
17,598,682
0
7,751,559
0
11,648,359
7,928,151
9,746,314
17,514,979
12,751,515
7,668,062
7,961,808
10,162,973
11,464,334
11,464,33410,162,9737,961,8087,668,06212,751,51517,514,9799,746,3147,928,15111,648,35907,751,559017,598,682033,074,14141,169,02838,139,032032,791,09533,064,260
       Inventory 
5,768,171
6,601,192
6,989,818
7,149,488
3,851,929
3,275,720
2,170,598
2,082,179
1,603,726
1,386,576
1,536,038
1,768,904
1,947,806
2,035,462
12,584,977
10,867,379
7,701,409
6,320,447
7,678,104
5,266,832
5,266,8327,678,1046,320,4477,701,40910,867,37912,584,9772,035,4621,947,8061,768,9041,536,0381,386,5761,603,7262,082,1792,170,5983,275,7203,851,9297,149,4886,989,8186,601,1925,768,171
       Other Current Assets 
675,982
717,421
1,577,701
26,515
492,595
827,701
839,282
-380,880
2,436,215
387,561
345,488
-380,879
-380,880
-369,921
-369,921
320,610
1,799,164
689,265
1,163,322
1
11,163,322689,2651,799,164320,610-369,921-369,921-380,880-380,879345,488387,5612,436,215-380,880839,282827,701492,59526,5151,577,701717,421675,982
   > Long-term Assets 
187,434,121
243,899,388
242,651,698
181,268,106
190,181,823
186,366,105
197,498,994
145,867,976
142,530,835
142,858,711
125,799,848
113,977,269
123,962,135
121,641,524
254,712,093
251,014,675
253,254,561
349,815,981
317,788,632
276,457,256
276,457,256317,788,632349,815,981253,254,561251,014,675254,712,093121,641,524123,962,135113,977,269125,799,848142,858,711142,530,835145,867,976197,498,994186,366,105190,181,823181,268,106242,651,698243,899,388187,434,121
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
95,149,742
92,088,796
95,579,712
96,342,104
77,702,072
72,918,303
72,918,30377,702,07296,342,10495,579,71292,088,79695,149,74200000000000000
       Goodwill 
48,801,442
51,374,321
0
22,603,377
0
0
22,603,377
1,895,884
1,895,884
1,895,884
1,895,884
0
0
0
38,464,734
21,924,796
0
0
0
1,772,113
1,772,11300021,924,79638,464,7340001,895,8841,895,8841,895,8841,895,88422,603,3770022,603,377051,374,32148,801,442
       Intangible Assets 
71,858,815
72,014,108
123,324,422
73,749,029
96,853,048
96,716,325
76,217,387
75,439,857
75,537,124
75,431,020
74,853,420
62,809,123
62,775,085
62,744,824
63,758,411
69,506,404
91,154,039
89,703,407
91,510,049
54,028,698
54,028,69891,510,04989,703,40791,154,03969,506,40463,758,41162,744,82462,775,08562,809,12374,853,42075,431,02075,537,12475,439,85776,217,38796,716,32596,853,04873,749,029123,324,42272,014,10871,858,815
       Long-term Assets Other 
1
-240
0
1
38,022
0
0
1
0
0
0
0
0
0
1
-1
152,406
260,890
0
0
00260,890152,406-1100000010038,02210-2401
> Total Liabilities 
94,861,964
131,719,325
65,747,673
70,510,315
70,568,794
63,552,599
41,656,106
39,452,826
35,955,192
40,483,766
30,170,630
24,187,700
19,549,031
105,626,392
188,612,012
175,723,723
176,859,682
176,754,364
189,518,781
192,287,513
192,287,513189,518,781176,754,364176,859,682175,723,723188,612,012105,626,39219,549,03124,187,70030,170,63040,483,76635,955,19239,452,82641,656,10663,552,59970,568,79470,510,31565,747,673131,719,32594,861,964
   > Total Current Liabilities 
46,026,084
43,351,188
39,064,927
39,844,715
39,783,648
29,759,679
20,276,035
17,865,344
13,773,007
17,740,547
7,287,395
13,535,842
8,847,736
15,225,325
40,788,518
26,784,511
26,564,026
23,926,772
32,170,897
135,456,990
135,456,99032,170,89723,926,77226,564,02626,784,51140,788,51815,225,3258,847,73613,535,8427,287,39517,740,54713,773,00717,865,34420,276,03529,759,67939,783,64839,844,71539,064,92743,351,18846,026,084
       Short-term Debt 
9,206,876
1,123,344
1,157,611
700,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000700,0001,157,6111,123,3449,206,876
       Short Long Term Debt 
8,095,477
1,123,344
1,157,611
700,000
0
0
0
0
0
1,000,000
0
0
0
125,000
8,932,200
8,307,200
10,639,150
11,142,200
18,844,000
113,821,148
113,821,14818,844,00011,142,20010,639,1508,307,2008,932,200125,0000001,000,00000000700,0001,157,6111,123,3448,095,477
       Accounts payable 
0
0
0
26,872,667
0
0
0
6,179,189
0
3,788,144
0
10,278,082
6,035,413
9,655,783
11,393,563
9,384,028
7,755,096
6,781,703
6,746,189
5,160,179
5,160,1796,746,1896,781,7037,755,0969,384,02811,393,5639,655,7836,035,41310,278,08203,788,14406,179,18900026,872,667000
       Other Current Liabilities 
2,553,067
174,690
913,379
-1
1,635,743
1,954,719
1,812,153
0
1,226,630
1,367,626
1,685,353
0
0
-1
29,868
27,659
758,679
1,136,116
1,942,116
1,471
1,4711,942,1161,136,116758,67927,65929,868-1001,685,3531,367,6261,226,63001,812,1531,954,7191,635,743-1913,379174,6902,553,067
   > Long-term Liabilities 
48,835,879
88,368,137
26,682,747
30,665,599
30,785,146
33,792,920
21,380,071
21,587,482
22,182,185
22,743,219
22,883,235
10,651,857
10,701,295
90,401,067
147,823,494
148,939,211
150,295,656
152,827,592
157,347,883
56,830,524
56,830,524157,347,883152,827,592150,295,656148,939,211147,823,49490,401,06710,701,29510,651,85722,883,23522,743,21922,182,18521,587,48221,380,07133,792,92030,785,14630,665,59926,682,74788,368,13748,835,879
       Long term Debt 
15,734,665
49,867,275
6,272,545
10,336,401
10,526,143
14,221,478
10,524,782
10,734,145
10,945,061
11,164,537
11,392,967
3,500,000
3,500,000
78,282,897
132,272,446
136,188,863
138,801,088
142,879,092
147,344,653
51,410,004
51,410,004147,344,653142,879,092138,801,088136,188,863132,272,44678,282,8973,500,0003,500,00011,392,96711,164,53710,945,06110,734,14510,524,78214,221,47810,526,14310,336,4016,272,54549,867,27515,734,665
       Capital Lease Obligations 
1,822,179
1,646,135
1,283,832
937,853
397,340
373,118
793,776
657,352
813,632
1,380,007
1,233,037
1,120,625
967,818
751,509
2,940,595
2,977,307
2,613,835
1,689,237
1,640,668
1,346,348
1,346,3481,640,6681,689,2372,613,8352,977,3072,940,595751,509967,8181,120,6251,233,0371,380,007813,632657,352793,776373,118397,340937,8531,283,8321,646,1351,822,179
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
-1
-100-10000000000000000
> Total Stockholder Equity
290,267,280
299,728,123
287,409,624
333,822,675
308,429,548
310,987,749
322,722,339
287,181,007
271,700,643
254,982,991
302,316,148
246,189,002
235,637,110
261,391,952
295,405,615
234,724,951
248,483,724
237,153,853
224,535,218
230,796,723
230,796,723224,535,218237,153,853248,483,724234,724,951295,405,615261,391,952235,637,110246,189,002302,316,148254,982,991271,700,643287,181,007322,722,339310,987,749308,429,548333,822,675287,409,624299,728,123290,267,280
   Common Stock00000000000000000000
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 00000000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue97,990,441
Cost of Revenue-98,739,015
Gross Profit-748,574-748,574
 
Operating Income (+$)
Gross Profit-748,574
Operating Expense-122,505,356
Operating Income-24,514,915-123,253,929
 
Operating Expense (+$)
Research Development5,454,490
Selling General Administrative5,532,760
Selling And Marketing Expenses0
Operating Expense122,505,35610,987,250
 
Net Interest Income (+$)
Interest Income1,288,438
Interest Expense-21,650,382
Other Finance Cost-2,505,561
Net Interest Income-22,867,505
 
Pretax Income (+$)
Operating Income-24,514,915
Net Interest Income-22,867,505
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,503,110-24,514,915
EBIT - interestExpense = -21,650,382
-5,983,400
15,666,982
Interest Expense21,650,382
Earnings Before Interest and Taxes (EBIT)015,147,272
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-6,503,110
Tax Provision--590,063
Net Income From Continuing Ops-5,913,047-5,913,047
Net Income-5,983,400
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net022,867,505
 

Technical Analysis of HLB Life Science Co.Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of HLB Life Science Co.Ltd. The general trend of HLB Life Science Co.Ltd is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine HLB Life Science Co.Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of HLB Life Science Co.Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 25,000.

The bearish price targets are: 16,280 > 15,800 > 14,010.

Tweet this
HLB Life Science Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of HLB Life Science Co.Ltd. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

HLB Life Science Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of HLB Life Science Co.Ltd. The current macd is -328.81063234.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the HLB Life Science Co.Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for HLB Life Science Co.Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the HLB Life Science Co.Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
HLB Life Science Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHLB Life Science Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of HLB Life Science Co.Ltd. The current adx is 24.79.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy HLB Life Science Co.Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
HLB Life Science Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of HLB Life Science Co.Ltd. The current sar is 18,751.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
HLB Life Science Co.Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of HLB Life Science Co.Ltd. The current rsi is 45.33. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
HLB Life Science Co.Ltd Daily Relative Strength Index (RSI) ChartHLB Life Science Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of HLB Life Science Co.Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the HLB Life Science Co.Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
HLB Life Science Co.Ltd Daily Stochastic Oscillator ChartHLB Life Science Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of HLB Life Science Co.Ltd. The current cci is -69.5668164.

HLB Life Science Co.Ltd Daily Commodity Channel Index (CCI) ChartHLB Life Science Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of HLB Life Science Co.Ltd. The current cmo is -15.88960254.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
HLB Life Science Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartHLB Life Science Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of HLB Life Science Co.Ltd. The current willr is -85.82677165.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
HLB Life Science Co.Ltd Daily Williams %R ChartHLB Life Science Co.Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of HLB Life Science Co.Ltd.

HLB Life Science Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of HLB Life Science Co.Ltd. The current atr is 1,306.

HLB Life Science Co.Ltd Daily Average True Range (ATR) ChartHLB Life Science Co.Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of HLB Life Science Co.Ltd. The current obv is 109,603,390.

HLB Life Science Co.Ltd Daily On-Balance Volume (OBV) ChartHLB Life Science Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of HLB Life Science Co.Ltd. The current mfi is 24.52.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
HLB Life Science Co.Ltd Daily Money Flow Index (MFI) ChartHLB Life Science Co.Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for HLB Life Science Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

HLB Life Science Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of HLB Life Science Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.331
Ma 20Greater thanMa 5018,820.000
Ma 50Greater thanMa 10017,015.800
Ma 100Greater thanMa 20014,140.600
OpenGreater thanClose16,640.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of HLB Life Science Co.Ltd with someone you think should read this too:
  • Are you bullish or bearish on HLB Life Science Co.Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about HLB Life Science Co.Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about HLB Life Science Co.Ltd

I send you an email if I find something interesting about HLB Life Science Co.Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about HLB Life Science Co.Ltd.

Receive notifications about HLB Life Science Co.Ltd in your mailbox!